COVID-19疫情期间乳腺放疗资源受限下的省略或缩短疗程策略
美国高容量综合癌症中心的多学科乳腺肿瘤专家在COVID-19疫情早期召开应急规划会议,复习相关文献并制定关于省略或缩短乳腺放疗的循证指南。结论认为,在公共卫生紧急状态下,节俭应用乳腺放疗可减轻临床负担而不损害长期肿瘤学结局,对不成熟研究数据的审慎个体化使用可能合理。
要点
- 某些有利风险乳腺亚组可考虑省略放疗。
- 全乳或胸壁放疗可选用大分割方案。
- 疫情下可审慎个体化使用不成熟数据缩短疗程。
核心结论
- 在公共卫生紧急状态下,节俭应用乳腺放疗可减轻临床负担而不损害长期肿瘤学结局。
研究设计与样本
- 美国高容量综合癌症中心的多学科乳腺肿瘤专家在COVID-19疫情早期召开应急规划会议,复习相关文献并制定推荐。
主要发现
- 有大量证据支持在某些有利风险乳腺癌亚组中省略放疗。
- 对需要全乳或乳房切除术后放疗(伴或不伴区域淋巴结覆盖)者,越来越多文献支持各种大分割方案安全有效。
关键数值与推荐
- 对有利风险亚组可考虑省略放疗。
- 全乳或胸壁放疗可选用大分割方案。
- 疫情下审慎个体化使用不成熟研究数据可能合理。
临床怎么用
- 根据患者风险分层和资源条件,个体化决定省略或缩短乳腺放疗疗程。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Breast radiation therapy accounts for a significant proportion of patient volume in contemporary radiation oncology practice. In the setting of anticipated resource constraints and widespread community infection with SARS-CoV-2 during the COVID-19 pandemic, measures for balancing both infectious and oncologic risk among patients and providers must be carefully considered. Here, we present evidence-based guidelines for omitting or abbreviating breast cancer radiation therapy, where appropriate, in an effort to mitigate risk to patients and optimize resource utilization. METHODS AND MATERIALS: Multidisciplinary breast cancer experts at a high-volume comprehensive cancer center convened contingency planning meetings over the early days of the COVID-19 pandemic to review the relevant literature and establish recommendations for the application of hypofractionated and abbreviated breast radiation regimens. RESULTS: Substantial evidence exists to support omitting radiation among certain favorable risk subgroups of patients with breast cancer and for abbreviating or accelerating regimens among others. For those who require either whole-breast or postmastectomy radiation, with or without coverage of the regional lymph nodes, a growing body of literature supports various hypofractionated approaches that appear safe and effective. CONCLUSIONS: In the setting of a public health emergency with the potential to strain critical healthcare resources and place patients at risk of infection, the parsimonious application of breast radiation therapy may alleviate a significant clinical burden without compromising long-term oncologic outcomes. The judicious and personalized use of immature study data may be warranted in the setting of a competing mortality risk from this widespread pandemic.
引用
- Braunstein LZ, Gillespie EF, Hong L, et al. Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States. Adv Radiat Oncol. 2020. PMID: 32292842. doi:10.1016/j.adro.2020.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。